Sort
51,593 grants matching “hepatitis”
Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan
$664,795Nabila El-Bassel · Columbia Univ New York Morningside · R01 · FY2017 · DA
Living Cell Arrays for Real Time Functional Genomics
$664,700Martin L Yarmush · Massachusetts General Hospital · R01 · FY2009 · AI
Activity Levels, Myosteatosis and Insulin Resistance/Diabetes Mellitus
$664,700Matthew A Allison · University Of California, San Diego · R01 · FY2023 · HL
Living Cell Arrays for Real Time Functional Genomics
$664,697Martin L Yarmush · Massachusetts General Hospital · R01 · FY2008 · AI
Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool
$664,679Haesuk Park · University Of Florida · R01 · FY2025 · DA
Molecular Mechanisms Of Hepatitis B Viral Pathogenesis And Persistence
$664,658T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
The Genetics of Disease Progression and Treatment Response in Hepatitis C
$664,658T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Restoring Central Regulation of Glucose Production in Type 2 Diabetes
$664,628Meredith A Hawkins · Albert Einstein College Of Medicine · R01 · FY2024 · DK
Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease
$664,616Philip Bauer · Endoprotech, Inc. · R44 · FY2015 · AA
Mycobacterium tuberculosis antigen diversity
$664,613Joel D. Ernst · New York University School Of Medicine · R01 · FY2010 · AI
Motivating Type O- Blood Donors to Return
$664,608Christopher R France · Ohio University Athens · R56 · FY2014 · HL
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
$664,443Frances Eun-Hyung Lee · Emory University · U01 · FY2019 · AI
Conserved Fetal Epigenomic and Metagenomic Signatures in a Primate Model of Maternal Obesity
$664,282Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · R01 · FY2017 · DK
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$664,278Douglas K Owens · Stanford University · R37 · FY2020 · DA
Health Promotion Coaching/Vaccine for Homeless Parolees
$664,263Adeline M Nyamathi · University Of California Los Angeles · R01 · FY2010 · DA
Mechanisms of Insulin Resistance in Man
$664,154Robert A. Rizza · Mayo Clinic Rochester · R01 · FY2009 · DK
Molecular Mechanisms of TGF-beta Signaling Pathway
$664,149Ying Zhang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study)
$664,132Richard Saitz · Boston University Medical Campus · U01 · FY2017 · AA
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
$664,100David L Thomas · Johns Hopkins University · R01 · FY2021 · DA
Proteomics Core
$664,058Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIC · FY2010 · HL
Gene Silencing as an Antiviral Defense in Animal Cells
$664,031Shou-Wei Ding · University Of California Riverside · R01 · FY2014 · AI
Identification and Characterization of Loci Associated with Non-alcoholic Fatty Liver Disease
$664,005Nicholette D. Allred · Wake Forest University Health Sciences · R01 · FY2023 · DK
Plasma protein synthesis and abundance in T1 diabetes
$663,986K. Sreekumaran Nair · Mayo Clinic Rochester · R33 · FY2008 · DK
Randomized Trial of Ibudilast for Methamphetamine Dependence
$663,956Keith Gregory Heinzerling · University Of California Los Angeles · R01 · FY2014 · DA
IL-27R signaling as a negative regulator of innate and adaptive anti-cancer immunity in hepatocellular carcinoma
$663,926Ekaterina Koltsova · Cedars-Sinai Medical Center · R01 · FY2022 · CA